Gerencia Fundación para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)

Clement What the numbers say about this buyer

• 31% of this buyer's awards went to companies that had already won here before (168 awards since 2024, spread over 100 companies). That is well below the national norm (53%) — this buyer switches suppliers more often than others.n = 168 awards since 2024
• The median procedure drew just one bid (28 procedures with a bid count); 50% ended with a single bidder. Country: median 1.1 bids.n = 28
• The award came in at a median 91% of the estimated value (91 awards with both estimate and value) — pricing at the estimate is usually too high here. Country: 87%.n = 91
• 73% of the bids received came from small and medium-sized enterprises (9 procedures with a bid mix). Country: 60%.n = 9
• Not one of the 168 awards with a known winner country has gone to a foreign company so far. National average: 0%.n = 168
• From notice to award takes a median 15 days here (30 procedures). Country: 14 days.n = 30

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 13/09/2026.